|
MLLT10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.87400000359628E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.51220000002661E-06 |
| Normal-vs-Stage2 |
3.60190000000538E-05 |
| Normal-vs-Stage3 |
7.31069999981848E-07 |
| Normal-vs-Stage4 |
3.69390000032332E-07 |
| Stage1-vs-Stage2 |
2.096200E-01 |
| Stage1-vs-Stage3 |
2.620200E-01 |
| Stage1-vs-Stage4 |
7.028200E-02 |
| Stage2-vs-Stage3 |
6.879800E-01 |
| Stage2-vs-Stage4 |
8.812800E-01 |
| Stage3-vs-Stage4 |
5.274200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.0657000049672E-08 |
| Normal-vs-AfricanAmerican |
1.025940E-02 |
| Normal-vs-Asian |
2.159300E-03 |
| Caucasian-vs-AfricanAmerican |
4.094200E-01 |
| Caucasian-vs-Asian |
2.438800E-01 |
| AfricanAmerican-vs-Asian |
9.642800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.25570000245546E-08 |
| Normal-vs-Female |
4.35809999976833E-07 |
| Male-vs-Female |
3.520800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.12240000000619E-05 |
| Normal-vs-Age(41-60Yrs) |
9.67660000017467E-07 |
| Normal-vs-Age(61-80Yrs) |
4.30869999679118E-08 |
| Normal-vs-Age(81-100Yrs) |
4.02580002667463E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.569000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.079900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.594700E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.716600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.763400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.443800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.759500E-02 |
| Classical-VS-Follicular |
1.276850E-01 |
| Classical-VS-Other |
4.768000E-01 |
| Classical-VS-Normal |
2.63089999996691E-06 |
| Tall-VS-Follicular |
5.453600E-01 |
| Tall-VS-Other |
8.766800E-01 |
| Tall-VS-Normal |
2.35999999999015E-05 |
| Follicular-VS-Other |
8.751600E-01 |
| Follicular-VS-Normal |
1.66195999999896E-05 |
| Other-VS-Normal |
2.184500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76569999954523E-07 |
| Normal-vs-N1 |
2.20389999999737E-05 |
| N0-vs-N1 |
9.210800E-01 |
|
|
